ILJIN SNT Co. Ltd. 13D and 13G filings for Aurinia Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-20 5:23 pm Purchase |
2024-03-20 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 7,539,891 13.000% |
355,993 (+4.96%) |
Filing |
| 2023-05-10 4:30 pm Unchanged |
2023-05-10 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 7,183,898 13.000% |
0 (Unchanged) |
Filing |
| 2023-01-20 4:30 pm Unchanged |
2023-01-19 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 7,183,898 13.000% |
0 (Unchanged) |
Filing |
| 2023-01-06 4:30 pm Sale |
2023-01-06 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 7,183,898 13.000% |
-1,093,902 (-13.21%) |
Filing |
| 2022-03-03 4:15 pm Sale |
2022-02-28 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 8,277,800 13.000% |
-717,639 (-7.98%) |
Filing |
| 2021-01-27 4:14 pm Sale |
2021-01-25 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 8,995,439 7.100% |
-1,536,675 (-14.59%) |
Filing |
| 2021-01-26 4:06 pm Sale |
2021-01-22 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 10,532,114 8.300% |
-1,237,922 (-10.52%) |
Filing |
| 2020-10-09 4:05 pm Sale |
2020-10-07 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 11,770,036 9.300% |
-631,491 (-5.09%) |
Filing |
| 2020-07-23 4:52 pm Sale |
2020-07-22 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 12,401,527 10.900% |
-1,308,252 (-9.54%) |
Filing |